GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of small win: GIP stopped being a problem at week 41 — 58 comments in the full submission. View in context.
2.2k
c/tirzepatide·submitted 1 year ago by u/crosspost_bot_no

small win: GIP stopped being a problem at week 41

Resultsbranch of 7 comments

Week 78 update. 19kg down from the start, early fullness basically gone since about week 23. Things that worked: consistency, protein at breakfast, walking more than I want to. Things that did not: everything I bought on the internet to help with early fullness. The part that surprised me is how much of this is…

Read the full submission and all 58 comments →

This branch

7 comments, started 1 year ago
u/britt_okwuosa428 points·1 year ago

This matches the trial data. SURMOUNT-1 was 97.9% body weight at 5 weeks.

replysharereportpermalink
[deleted]301 points·1 year ago

[deleted]

replysharereportpermalink
u/gustav_vermeulen111 points·1 year ago

the GIP side does different things than the GLP-1 side, that is the point

replysharereportpermalink
u/ewan_marchand206 points·1 year ago

do not crack the pen, we have been over this

replysharereportpermalink
u/copay_card_cc142 points·1 year ago

Slight fix: the number was 99.1, not 93.7. Decimal point, but a fairly consequential one.

replysharereportpermalink
load more comments (2) →

← back to the whole thread

About c/tirzepatide

Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.

187kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/tirzepatide
c/tirzepatide rules
  1. "Tirz is better than sema" needs a comparator dose or it is a vibe, not a claim.
  2. Vial-splitting and self-compounding discussion stays in c/reconstitution.
  3. No pen-cracking tutorials. Discussing that people do it is fine; instructions are not.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/titration_marshalu/incretin_ivyu/quiet_moderatoru/dexa_twice_yearly
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →